Response to Comments: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers

The provided excerpt (Policy A59853) contains only administrative information about comment and notice periods for MolDX LCDs DL39636 and L39688 and does not include any clinical coverage criteria, indications, limitations, documentation requirements, or frequency limits. A full review of the referenced LCD documents (DL39636/L39688) is required to extract actionable coverage criteria; manual review recommended to complete extraction.

"No clinical coverage exclusions or limitations are present in the provided text; the excerpt contains only administrative notice/comment-period information."

Sign up to see full coverage criteria, indications, and limitations.